Dr. Fouse has served on the Board since 2010. Dr. Fouse currently serves as the President and Chief Operating Officer of Celgene Corporation, a global biopharmaceutical company listed on Nasdaq, a position she has held since March 2016. Dr. Fouse served as President, Global Hematology and Oncology from August 2014 to March 2016. From September 2010 to August 2014, Dr. Fouse served as the Chief Financial Officer of Celgene. She formerly served as Chief Financial Officer of Bunge Limited, a global agribusiness and food company listed on the NYSE, from 2007 to 2010. From 2006 to 2007, Dr. Fouse was the Senior Vice President, Chief Financial Officer and Corporate Strategy Officer at Alcon, Inc., a global eye care company listed on the NYSE, and from 2002 she was Alcon’s Senior Vice President and Chief Financial Officer. Dr. Fouse served as the Chief Financial Officer of Swiss Air Group in Switzerland from 2001 to 2002. Previously, Dr. Fouse held a variety of senior finance positions at Alcon and its then majority owner Nestlé SA. Dr. Fouse was elected as a member of the board of directors of Celgene in February 2016. Subsequent to that event she chose not to stand for re-election to the Perrigo Company board in April 2016 after serving three and one-half years. She also serves on the advisory boards at the University of Texas at Arlington and Texas Christian University.